Sfoglia per Autore
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
2001 Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G.
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one
2002 Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti G.; Baccarani M.
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8]
2003 Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifazi F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G.
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC
2003 Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccaluga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G.
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
2004 ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE;
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia
2004 PICCALUGA PP; MALAGOLA M; RONDONI M; AMABILE M; PAOLINI S; SOVERINI S; GAITANI S; VISANI G; BACCARANI M.; MARTINELLI G
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia
2004 BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S.; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA
Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib
2004 SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M.
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
2004 PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G.
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP.
2005 Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
2005 Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M.
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia
2005 Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M.
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
2006 Catani L.; Fagioli M.E.; Tazzari P.L.; Ricci F.; Curti A.; Rovito M.; Preda P.; Chirumbolo G.; Amabile M.; Lemoli R.M.; Tura S.; Conte R.; Baccarani M.; Vianelli N.
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
2006 Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cilloni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies
2006 Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.; Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G.
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies
2006 Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.; Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G.
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia
2006 Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML)
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
2006 MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TESTONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M.
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
2006 IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFUSCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
2007 Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia | Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici ...S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G. | 2001-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one | Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti ...G.; Baccarani M. | 2002-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] | Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifaz...i F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G. | 2003-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC | Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccal...uga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G. | 2003-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Molecular response to imatinib in late chronic-phase chronic myeloid leukemia | ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE... VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE; | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia | PICCALUGA PP; MALAGOLA M; RONDONI M; AMABILE M; PAOLINI S; SOVERINI S; GAITANI S; VISANI G; BACCA...RANI M.; MARTINELLI G | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia | BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S....; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib | SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M. | 2004-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. | PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M....; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. | Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; O...ttaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G | 2005-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? | Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; B...asi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia | Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagn...etti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M. | 2005-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. | Catani L.; Fagioli M.E.; Tazzari P.L.; Ricci F.; Curti A.; Rovito M.; Preda P.; Chirumbolo G.; Am...abile M.; Lemoli R.M.; Tura S.; Conte R.; Baccarani M.; Vianelli N. | 2006-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. | Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cill...oni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G | 2006-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies | Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. | 2006-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies | Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. | 2006-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia | Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruz...zese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML) | 2006-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients | MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TEST...ONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. | IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFU...SCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis. | Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin ...R; Martinelli G; Baccarani M. | 2007-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile